P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma (Q81537128)

From Wikidata
Jump to navigation Jump to search
scientific article published on 08 January 2005
edit
Language Label Description Also known as
English
P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma
scientific article published on 08 January 2005

    Statements

    P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit